UAMY Earnings Prediction
The chart below shows how UAMY performed 10 days before and after its earnings report, based on data from the past quarters. Typically, UAMY sees a -5.92% change in stock price 10 days leading up to the earnings, and a +19.91% change 10 days following the report. On the earnings day itself, the stock moves by +7.53%. This data can give you a slight idea of what to expect for the next quarter's release.
UAMY Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
2.42M
4.65%
-13.96%
Gross Margin
17.59%
138.36%
-45.52%
Operating Margin
-35.58%
-54.89%
368.77%
Net Margin
-28.22%
-60.30%
1325.25%
EPS
-0.01
-50.00%
--
No Data Available
UAMY Earnings Analysis
United States Antimony Corporation Corporation (UAMY.A) Earnings Conference Call
Positive
Sales Growth Surge: Sales increased by 23% year-over-year, reaching $8.1 million for the first nine months of the year, driven by higher antimony sales volume and prices.
Gross Profit Surge: Gross profit for the first nine months of this year was $2.2 million, reflecting a 107% increase compared to last year, primarily due to improved efficiencies with higher volume.
Antimony Sales Surge: Antimony business sales increased by 24% over the prior year, contributing to a significant rise in gross profit margins compared to last year.
Cash Balance Increase: The company's cash and cash equivalents balance increased to $12.97 million as of September 30, 2024, up by $1.1 million from December 31, 2023, indicating strong liquidity.
Operational Enhancements in Zeolite: The company has made substantial progress in enhancing operations at its zeolite business, leading to higher production reliability and improved customer delivery timing.
Negative
Sales Increase Analysis: Sales were $8.1 million for the first nine months of this year, which is an increase of 23% compared to last year. This increase was primarily related to higher antimony sales volume with higher demand and to a lesser extent higher zeolite sales volume and sales price.
Gross Profit Surge: Gross profit was $2.2 million for the first nine months of this year, which is an increase of 107% over last year. This increase was primarily due to improved efficiencies with the higher volume, partially offset by more maintenance and other related costs with our zeolite business, which I'll talk more about later.
Operating Expenses Increase: Operating expenses were $3.3 million for the first nine months of 2024, an increase of $1.8 million compared to 2023. This increase was primarily related to about $454,000 of non-cash stock compensation expense, $446,000 of project costs, $482,000 of salary and board fee expenses, and $90,000 of SEC and annual meeting costs that were incurred earlier this year, but not until the fourth quarter of last year.
Zeolite Sales Performance: Sales from our zeolite business for the first nine months of this year increased by 17% over the prior year. Gross profit decreased by $255,000 compared to last year, and loss from operations was worse by $562,000.
Zeolite Supply and Sales Growth: During the third quarter, we also substantially increased our supply of material from our zeolite mine to continue timely delivery of product to our customers, and we saw some increased sales volume in the animal feed sector. Overall, these improvements at our Bear River Zeolite facility allow us to grow our zeolite business, which hasn't happened in prior years.
UAMY FAQs
How does UAMY typically perform around its earnings report dates?
Is United States Antimony Corporation (UAMY) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
UAMY Earning Call Sentiment
United States Antimony Corporation (UAMY) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
UAMY.A
-7.65%Positive
The earnings report highlights increased operational costs and losses in the zeolite business, a canceled acquisition due to insufficient reserves, and reliance on government contracts, which are potential risks. Despite increased sales and gross profit, the operating expenses surged, impacting profitability. The Q&A revealed uncertainties about antimony reserves and feedstock agreements, reflecting management's lack of clarity. The ATM filing suggests potential future funding needs, which could dilute shareholder value. Overall, these factors suggest a negative sentiment, likely leading to a stock price decline of -2% to -8% over the next two weeks.
